SCHEMBL23219141

SCHEMBL23219141

CCOC(=O)c1c(C)oc2c1cc(Br)c1oc(C)cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.56
GAA P10253 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
NPC1 O15118 2/20 0.56
RECQL P46063 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
TSHR P16473 3/20 0.48
MAPK1 P28482 2/20 0.47
PKM P14618 1/20 0.47
HTT P42858 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HSD17B10 Q99714 2/20 0.47
ALOX15 P16050 1/20 0.47
ALOX5 P09917 2/20 0.46
RXFP1 Q9HBX9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29592686 1.00 MAPT (0.56) MAPTGAAMEN1KMT2ANPC1
SCHEMBL23218859 0.83 MAOB (0.55) MAPTGAAMEN1KMT2ANPC1
SCHEMBL23219016 0.82 MAPT (0.57) MAPTGAAMEN1KMT2ANPC1
SCHEMBL29591076 0.82 MAPT (0.57) MAPTGAAMEN1KMT2ANPC1
SCHEMBL23218735 0.82 POLB (0.40) MAPTGAAMEN1KMT2ANPC1
SCHEMBL29591463 0.82 POLB (0.40) MAPTGAAMEN1KMT2ANPC1
SCHEMBL23218406 0.79 MAOB (0.45) MAPTGAAKMT2ATSHRMAPK1
SCHEMBL17918887 0.73 MAPT (0.66) MAPTGAAMEN1KMT2ANPC1
SCHEMBL16453510 0.72 MAPT (0.69) MAPTGAAMEN1KMT2ANPC1
SCHEMBL24471133 0.72 CYP3A4 (0.61) MAPTGAAMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041238-A1 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-08-17 EP disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed